| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |